Your browser doesn't support javascript.
loading
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma.
Thurner, Lorenz; Fadle, Natalie; Regitz, Evi; Roth, Sophie; Cetin, Onur; Kos, Igor Age; Hess, Simon Mauro; Bein, Julia; Bohle, Rainer Maria; Vornanen, Martine; Sundström, Christer; De Leval, Laurence; Tiacci, Enrico; Borchmann, Peter; Engert, Andreas; Poeschel, Viola; Held, Gerhard; Schwarz, Eva C; Neumann, Frank; Preuss, Klaus-Dieter; Hoth, Markus; Küppers, Ralf; Lehman, Karola; Hansmann, Martin-Leo; Becker, Sören L; Bewarder, Moritz; Hartmann, Sylvia.
Afiliación
  • Thurner L; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar. lorenz.thurner@uks.eu.
  • Fadle N; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Regitz E; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Roth S; Institute of Medical Microbiology and Hygiene, Saarland University, Homburg.
  • Cetin O; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Kos IA; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Hess SM; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Bein J; Dr. Senckenberg Institute of Pathology, Goethe University Hospital of Frankfurt am Main, Theodor-Stern-Kai.
  • Bohle RM; Saarland University Medical School, Institute of Pathology, Homburg/Saar.
  • Vornanen M; Department of Pathology, Tampere University Hospital and University of Tampere, Tampere 33520, Finland. Martine.vornanen@fimlab.fi.
  • Sundström C; Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden. christer.sundstrom@akademiska.se.
  • De Leval L; D-60590 Frankfurt a. Main. julia.bein@kgu.de.
  • Tiacci E; Institute of Hematology, Ospedale S. Maria della Misericordia, and the Department of Medicine, University of Perugia.
  • Borchmann P; University of Cologne, First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Cologne. a.engert@uni-koeln.de.
  • Engert A; University of Cologne, First Department of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Cologne. a.engert@uni-koeln.de.
  • Poeschel V; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Held G; Department of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern.
  • Schwarz EC; Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg.
  • Neumann F; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Preuss KD; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Hoth M; Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg.
  • Küppers R; Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Medical School, Essen, Germany; and Deutsches Konsortium für translationale Krebsforschung (DKTK).
  • Lehman K; Proteome Factory AG, Berlin.
  • Hansmann ML; Frankfurt Institute for Advanced Studies, Frankfurt am Main, Germany; Institute of Pathology and Molecular Pathology, Helios University Hospital Wuppertal.
  • Becker SL; Institute of Medical Microbiology and Hygiene, Saarland University, Homburg.
  • Bewarder M; José Carreras Center for Immuno-and Gene Therapy and Internal Medicine I, Saarland University Medical School, Homburg/Saar.
  • Hartmann S; Dr. Senckenberg Institute of Pathology, Goethe University Hospital of Frankfurt am Main, Theodor-Stern-Kai.
Haematologica ; 108(12): 3347-3358, 2023 Dec 01.
Article en En | MEDLINE | ID: mdl-37139600
ABSTRACT
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a Hodgkin lymphoma expressing functional B-cell receptors (BCR). Recently, we described a dual stimulation model of IgD+ lymphocyte-predominant cells by Moraxella catarrhalis antigen RpoC and its superantigen MID/hag, associated with extralong CDR3 and HLA-DRB1*04 or HLADRB1* 07 haplotype. The aim of the present study was to extend the antigen screening to further bacteria and viruses. The fragment antibody-binding (Fab) regions of seven new and 15 previously reported cases were analyzed. The reactivity of non-Moraxella spp.-reactive Fab regions against lysates of Rothia mucilaginosa was observed in 5/22 (22.7%) cases. Galactofuranosyl transferase (Gltf) and 2,3-butanediol dehydrogenase (Bdh) of R. mucilaginosa were identified by comparative silver- and immuno-staining in two-dimensional gels, with subsequent mass spectrometry and validation by western blots and enzyme-linked immunosorbent assay. Both R. mucilaginosa Gltf and Bdh induced BCR pathway activation and proliferation in vitro. Apoptosis was induced by recombinant Gltf/ETA'-immunotoxin conjugates in DEV cells expressing recombinant R. mucilaginosa-reactive BCR. Reactivity against M. catarrhalis RpoC was confirmed in 3/7 newly expressed BCR (total 10/22 reactive to Moraxella spp.), resulting in 15/22 (68.2%) cases with BCR reactivity against defined bacterial antigens. These findings strengthen the hypothesis of bacterial trigger contributing to subsets of NLPHL.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Micrococcaceae Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Micrococcaceae Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article